General Biologicals Market Cap

General Biologicals has a market cap or net worth of 471.39 million as of March 9, 2026. Its market cap has decreased by -56.94% in one year.

Market Cap

471.39M

Enterprise Value

2.79B

Revenue

251.38M

Ranking

n/a

PE Ratio

n/a

Stock Price

9.30

Market Cap Chart

Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 471.39M, an increase of 44.17%. That is a compound annual growth rate of 1.75%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	471.39M	-39.69%
Dec 31, 2025	781.60M	-38.66%
Dec 31, 2024	1.27B	-21.11%
Dec 29, 2023	1.62B	0.37%
Dec 30, 2022	1.61B	-22.70%
Dec 30, 2021	2.08B	-35.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bioray Biotech	710.05M
UniPharma	440.21M
Prince Pharmaceutical	1.05B
Mediera	1.06B
Original BioMedicals	1.11B
Anxo Pharmaceutical	1.13B
Excelsior Biopharma	1.26B
DV Biomed	1.34B

Market Cap Rankings